[go: up one dir, main page]

JP7054111B2 - 乳酸菌、該乳酸菌由来の血糖低下剤、糖尿病治療薬、及び飲食品 - Google Patents

乳酸菌、該乳酸菌由来の血糖低下剤、糖尿病治療薬、及び飲食品 Download PDF

Info

Publication number
JP7054111B2
JP7054111B2 JP2018534279A JP2018534279A JP7054111B2 JP 7054111 B2 JP7054111 B2 JP 7054111B2 JP 2018534279 A JP2018534279 A JP 2018534279A JP 2018534279 A JP2018534279 A JP 2018534279A JP 7054111 B2 JP7054111 B2 JP 7054111B2
Authority
JP
Japan
Prior art keywords
lactic acid
acid bacterium
product
strain
sucrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018534279A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2018034047A1 (ja
Inventor
和久 関水
靖彦 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Genome Pharmaceuticals Institute Co Ltd
Original Assignee
University of Tokyo NUC
Genome Pharmaceuticals Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC, Genome Pharmaceuticals Institute Co Ltd filed Critical University of Tokyo NUC
Publication of JPWO2018034047A1 publication Critical patent/JPWO2018034047A1/ja
Application granted granted Critical
Publication of JP7054111B2 publication Critical patent/JP7054111B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99—Enzyme inactivation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2018534279A 2016-08-16 2017-06-15 乳酸菌、該乳酸菌由来の血糖低下剤、糖尿病治療薬、及び飲食品 Active JP7054111B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016159555 2016-08-16
JP2016159555 2016-08-16
PCT/JP2017/022052 WO2018034047A1 (fr) 2016-08-16 2017-06-15 Bactérie lactique, agent hypoglycémiant dérivé de celle-ci, agent thérapeutique du diabète, et boisson et aliment

Publications (2)

Publication Number Publication Date
JPWO2018034047A1 JPWO2018034047A1 (ja) 2019-06-13
JP7054111B2 true JP7054111B2 (ja) 2022-04-13

Family

ID=61196619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018534279A Active JP7054111B2 (ja) 2016-08-16 2017-06-15 乳酸菌、該乳酸菌由来の血糖低下剤、糖尿病治療薬、及び飲食品

Country Status (2)

Country Link
JP (1) JP7054111B2 (fr)
WO (1) WO2018034047A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020184909A (ja) * 2019-05-13 2020-11-19 学校法人帝京大学 血糖降下剤、及び、該血糖降下剤を含有する飲食品
WO2021070829A1 (fr) * 2019-10-11 2021-04-15 国立大学法人静岡大学 Bactéries d'acide lactique qui produisent du nicotinamide riboside, et bactéries d'acide lactique qui produisent du nicotinamide mononucléotide et du nicotinamide riboside
WO2021080298A1 (fr) * 2019-10-24 2021-04-29 (주)닥터티제이 Composition contenant enterococus faecalis en guise de principe actif pour la prévention ou le traitement de l'obésité ou de syndromes métaboliques induits par cette dernière
WO2024237318A1 (fr) * 2023-05-16 2024-11-21 ミヤリサン製薬株式会社 Agent inhibiteur de la consommation/du métabolisme/de la récompense de sucre et son utilisation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003116486A (ja) 2001-08-09 2003-04-22 Meiji Milk Prod Co Ltd 食後の血糖上昇抑制作用を有する食品組成物
JP2009058500A (ja) 2007-08-06 2009-03-19 Genome Soyaku Kenkyusho:Kk 血糖値を降下させる物質の評価方法、スクリーニング方法及び製造方法
WO2010004916A1 (fr) 2008-07-08 2010-01-14 株式会社ゲノム創薬研究所 Agent hypoglycémique, et aliment ou boisson pour la prévention du diabète ou l'amélioration d'un état de diabète le comprenant
WO2012011174A1 (fr) 2010-07-22 2012-01-26 ビオフェルミン製薬株式会社 Agent améliorant le métabolisme des lipides, agent amplifiant l'effet améliorant sur le métabolisme des lipides, agent anti-obésité et agent amplifiant l'effet anti-obésité

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH107577A (ja) * 1996-06-17 1998-01-13 Yakult Honsha Co Ltd 血糖降下剤
WO2017061353A1 (fr) * 2015-10-08 2017-04-13 株式会社ゲノム創薬研究所 Procédé d'évaluation, procédé de criblage et procédé de production de substances qui empêchent des augmentations des valeurs de sucre dans le sang dues à l'ingestion de saccharose

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003116486A (ja) 2001-08-09 2003-04-22 Meiji Milk Prod Co Ltd 食後の血糖上昇抑制作用を有する食品組成物
JP2009058500A (ja) 2007-08-06 2009-03-19 Genome Soyaku Kenkyusho:Kk 血糖値を降下させる物質の評価方法、スクリーニング方法及び製造方法
WO2010004916A1 (fr) 2008-07-08 2010-01-14 株式会社ゲノム創薬研究所 Agent hypoglycémique, et aliment ou boisson pour la prévention du diabète ou l'amélioration d'un état de diabète le comprenant
WO2012011174A1 (fr) 2010-07-22 2012-01-26 ビオフェルミン製薬株式会社 Agent améliorant le métabolisme des lipides, agent amplifiant l'effet améliorant sur le métabolisme des lipides, agent anti-obésité et agent amplifiant l'effet anti-obésité

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Scientific Reports，2016年05月19日，Vol. 6: 26354，p. 1-9

Also Published As

Publication number Publication date
JPWO2018034047A1 (ja) 2019-06-13
WO2018034047A1 (fr) 2018-02-22

Similar Documents

Publication Publication Date Title
CN102970997B (zh) 抗肥胖剂、抗肥胖用饮食品、糖耐量改善剂和糖耐量改善用饮食品
EP2457992B1 (fr) Nouvelle souche de lactobacillus plantarum et composition la contenant
CA2609617C (fr) Lactobacilli felins a activite probiotique
JP6505018B2 (ja) 新規乳酸菌、新規乳酸菌を有効成分とする自然免疫活性化剤、及び新規乳酸菌を含有する飲食品
US10265352B2 (en) Lactic acid bacteria, natural immunoactivator and infection preventative/therapeutic derived from said lactic acid bacteria, and food/beverage
US8728461B2 (en) Lactic acid bacterium having high immunoglobulin-A-inducing ability
JP7054111B2 (ja) 乳酸菌、該乳酸菌由来の血糖低下剤、糖尿病治療薬、及び飲食品
JP7555439B2 (ja) 骨格筋遅筋化用組成物
CN116209363A (zh) 生成α-葡萄糖苷酶抑制剂的新型凝结芽孢杆菌CC菌株
JP6793380B2 (ja) スクロース摂取による血糖値上昇を抑制する物質の評価方法、スクリーニング方法及び製造方法
JP7090288B2 (ja) 新規乳酸菌、新規乳酸菌を有効成分として含有する自然免疫活性化剤、及び新規乳酸菌を含有する飲食品
JP7369976B2 (ja) 乳酸菌、該乳酸菌由来の自然免疫活性化剤、感染症予防・治療薬及び飲食品
JP6245583B2 (ja) カテコールアミン認識性を指標に選抜した微生物とカテコールアミン含有組成物
JP2015500016A (ja) ロイテリン産生ラクトバチルス・ブレビス
KR102495246B1 (ko) 체지방 감소 활성을 갖는 락토바실러스 헬베티쿠스 bcc-lh-04 및 이를 포함하는 조성물
JP2020184909A (ja) 血糖降下剤、及び、該血糖降下剤を含有する飲食品
JP6588509B2 (ja) 乳酸菌を有効成分として含有する抗真菌剤
CN103184170B (zh) 一种新型乳酸杆菌ly-73及其应用
WO2024090414A1 (fr) Bactérie d'acide lactique, agent d'immunoactivation naturel dérivé de ladite bactérie d'acide lactique, et aliment contenant ladite bactérie d'acide lactique
HK1219501B (zh) 新型乳酸菌、以新型乳酸菌作为有效成分的天然免疫活化剂以及含有新型乳酸菌的饮食品
RS54225B1 (sr) Autohtoni lactobacillus sojevi i njihova upotreba kao probiotika

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200609

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210803

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220301

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220322

R150 Certificate of patent or registration of utility model

Ref document number: 7054111

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250